What is the appropriate treatment for nipple eczema?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nipple Eczema: Evidence-Based Treatment Approach

Start with low-potency topical corticosteroids (hydrocortisone 1–2.5% cream) applied twice daily to the affected nipple skin, combined with intensive emollient therapy and avoidance of irritants; both topical corticosteroids and calcineurin inhibitors are safe during lactation. 1

First-Line Topical Therapy

Topical Corticosteroid Selection

  • Apply hydrocortisone 1–2.5% cream no more than twice daily to the nipple for 2–4 weeks as the initial treatment, as this low-potency preparation provides adequate anti-inflammatory effect while minimizing the risk of skin atrophy in this thin-skinned area. 2, 1
  • Topical corticosteroids are considered safe during breastfeeding when used appropriately on the nipple, allowing mothers to continue nursing without interruption. 1, 3
  • Avoid very potent or potent corticosteroids on the nipple due to the high risk of atrophy and systemic absorption in this sensitive location. 4

Calcineurin Inhibitor Alternative

  • Topical calcineurin inhibitors (tacrolimus 0.03–0.1% ointment or pimecrolimus 1% cream) are effective steroid-sparing alternatives that do not cause skin atrophy, making them particularly suitable for long-term nipple eczema management. 4, 1
  • These agents are also safe during lactation and can be used when corticosteroid-related concerns exist. 1

Essential Adjunctive Measures

Intensive Emollient Therapy

  • Apply fragrance-free emollients liberally and frequently to the nipple, especially immediately after bathing or washing, to restore the skin barrier and reduce transepidermal water loss. 4, 2, 1
  • Continue emollient use even when the eczema appears controlled, as this provides documented steroid-sparing benefits and prolongs remission. 4, 2

Avoidance of Irritants and Allergens

  • Replace regular soaps with soap-free cleansers or dispersible cream cleansers to preserve natural skin lipids. 5, 2, 1
  • Identify and eliminate provoking factors such as repetitive friction, chemical agents (lanolin, fragrances, preservatives in topical products), or contact allergens. 1, 3, 6
  • For breastfeeding mothers, nipple protection devices can reduce mechanical trauma during nursing. 1
  • Adjusting latch/suck positioning during breastfeeding may be necessary to minimize friction-induced irritation. 1, 3

Symptomatic Relief Measures

  • Warm water compresses, black tea compresses, or commercially available tannin-containing topicals can provide comfort and reduce inflammation. 1

Management of Secondary Infections

Bacterial Superinfection

  • Watch for increased crusting, weeping, purulent exudate, or pustules, which indicate secondary bacterial infection, most commonly Staphylococcus aureus. 5, 2, 3, 6
  • Prescribe oral flucloxacillin as first-line antibiotic therapy (or erythromycin for penicillin allergy) while continuing topical corticosteroids concurrently. 2, 3, 6

Fungal Infection (Candidiasis)

  • Consider nipple candidiasis in the differential diagnosis, particularly in breastfeeding mothers with persistent symptoms despite appropriate eczema treatment. 1, 3, 6
  • Obtain swabs for culture when diagnostic uncertainty exists or when initial therapy fails. 5, 1

Eczema Herpeticum (Medical Emergency)

  • Suspect eczema herpeticum if grouped vesicles, punched-out erosions, or sudden deterioration with fever develop—this requires immediate oral or intravenous acyclovir. 2, 3, 6

Proactive Maintenance After Clearance

  • After achieving clinical clearance, apply the same low-potency corticosteroid twice weekly (e.g., weekend therapy) to previously affected nipple skin for up to 16 weeks to prevent relapse and reduce the risk of post-inflammatory changes. 4
  • Alternatively, use topical calcineurin inhibitors 2–3 times weekly as steroid-sparing maintenance therapy. 4

Critical Differential Diagnoses to Exclude

  • Paget's disease of the nipple must be excluded in cases of unilateral, persistent, or treatment-resistant "eczema," particularly when accompanied by nipple discharge or an underlying mass. 1, 7
  • In cases of diagnostic uncertainty, perform a skin biopsy to distinguish true eczematous dermatitis (spongiotic pattern) from Paget's disease (pagetoid infiltration of atypical cells). 1, 7
  • Other differential diagnoses include nipple psoriasis and nipple candidiasis. 1, 6

Common Pitfalls to Avoid

  • Do not delay or withhold topical corticosteroids when bacterial infection is present—continue anti-inflammatory therapy while administering appropriate systemic antibiotics. 2
  • Do not use topical corticosteroids continuously without breaks; implement "steroid holidays" or step down to maintenance therapy after initial control. 5, 2
  • Avoid non-sedating antihistamines, as they have no proven benefit in eczema management. 2
  • Address steroid phobia proactively by explaining that low-potency corticosteroids are safe for nipple use during lactation, as fear of steroids often leads to undertreatment and premature breastfeeding cessation. 2, 1, 8

When to Refer or Escalate

  • Refer for dermatology consultation if nipple eczema fails to respond to moderate-potency topical corticosteroids after 4 weeks of appropriate use. 2
  • Obtain urgent dermatology or surgical evaluation for suspected Paget's disease (unilateral, persistent, or atypical presentation). 1, 7
  • Consider systemic therapy (phototherapy, immunosuppressants, biologics) for severe, refractory cases that significantly impact quality of life or breastfeeding. 5, 9

References

Research

Nipple eczema: A systematic review and practical recommendations.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2023

Guideline

Treatment of Eczema (Atopic Dermatitis)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guidelines for Eczema Management and Prevention of Post‑Inflammatory Scarring

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Dermatoses of the breast in lactation.

Dermatologic therapy, 2013

Research

Nipple and areolar eczema in the breastfeeding woman.

Journal of cutaneous medicine and surgery, 2004

Research

European Guideline (EuroGuiDerm) on atopic eczema: Living update.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.